๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

โœ Scribed by Afshin Dowlati; James Posey; Ramesh K. Ramanathan; Linda Rath; Pingfu Fu; Amitabh Chak; Smitha Krishnamurthi; Joanna Brell; Stephen Ingalls; Charles L. Hoppel; Percy Ivy; Scot C. Remick

Publisher
Springer
Year
2009
Tongue
English
Weight
274 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Expanded phase II trial of gemcitabine a
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
โœ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger

Phase II trial of menogaril in advanced
Phase II trial of menogaril in advanced colorectal cancer
โœ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach